A drug support body is provided that can be used to appropriately administer a drug to the anterior segment of the eye while the production cost is reduced. A drug layer 2 containing a drug component to be administered to an anterior segment of the eye is provided at a halfway portion in a longitudinal direction of a base plate 3, wherein the base plate 3 includes a bending portion 4 that allows the base plate 3 to bend in a direction opposite to a surface of the base plate 3 on which the drug layer 2 is provided, and by bending the base plate 3 at the bending portion 4, at least a portion of a surface facing the base plate 3 of the drug layer 2 is exposed from the base plate 3.
